Akoustis Technologies (AKTSQ) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
13 Jun, 2025Executive summary
Revenue increased to $9.0 million for the quarter ended September 30, 2024, up from $7.0 million year-over-year, driven by higher fabrication service revenue.
Net loss narrowed to $6.4 million from $20.1 million year-over-year, reflecting higher sales and significant cost reductions in R&D and G&A.
The company faces severe liquidity constraints due to a $57.7 million litigation-related contingent liability and may be forced to seek bankruptcy protection without additional financing or a successful appeal.
A permanent injunction restricts the sale of certain products and requires costly compliance measures following an adverse litigation outcome.
Financial highlights
Revenue rose 28.9% year-over-year to $9.0 million, with fabrication services up 55.9%.
Cost of revenue decreased to $4.7 million from $8.1 million, improving gross margin to $4.3 million.
R&D expenses fell 74% to $2.7 million; G&A expenses dropped 32% to $6.9 million.
Net loss per share improved to $(0.04) from $(0.28) year-over-year.
Cash and equivalents declined to $12.1 million from $24.4 million at June 30, 2024.
Outlook and guidance
Existing cash resources are expected to fund operations only into the third quarter of fiscal 2025 without additional liquidity.
The company is actively seeking additional capital and managing cash outflows, but there is substantial doubt about its ability to continue as a going concern.
Latest events from Akoustis Technologies
- Key votes include director elections, executive pay, a reverse stock split, and auditor ratification.AKTSQ
Proxy Filing1 Dec 2025 - Key votes include director elections, a reverse stock split, and auditor ratification.AKTSQ
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay, a reverse stock split, and auditor ratification.AKTSQ
Proxy Filing1 Dec 2025 - Annual Meeting adjourned for lack of quorum; voting extended to December 12, 2024.AKTSQ
Proxy Filing1 Dec 2025 - Annual meeting adjourned for lack of quorum; voting extended to January 9, 2025.AKTSQ
Proxy Filing1 Dec 2025 - Shareholders to vote on a reverse split as Nasdaq grants conditional continued listing.AKTSQ
Proxy Filing1 Dec 2025 - Kingsdale was engaged to assist with proxy solicitation for the 2024 annual meeting.AKTSQ
Proxy Filing1 Dec 2025 - Severe litigation losses and asset impairments drove Akoustis to a $167.9M net loss and liquidity crisis.AKTSQ
Q4 202413 Jun 2025